Original Investigation

Prediction of metabolic syndrome in women with polycystic ovary syndrome


  • Fırat Ersan
  • Esra Arslan
  • Aytül Çorbacıoğlu Esmer
  • Serdar Aydın
  • Asuman Gedikbaşı
  • Ali Gedikbaşı
  • İsmet Alkış
  • Cemal Ark

Received Date: 26.04.2012 Accepted Date: 15.07.2012 J Turk Ger Gynecol Assoc 2012;13(3):178-183 PMID: 24592034


To identify biochemical factors that serve as predictors for the metabolic syndrome (MetS) in patients with polycystic ovary syndrome (PCOS) and to investigate the value of adipocytokines in the prediction of metabolic syndrome.

Material and Methods:

A total of 91 pre-menopausal women with PCOS diagnosed according to the Rotterdam consensus criteria were recruited as study subjects. Waist circumference, blood pressure, body mass index (BMI), fasting glucose, serum lipids, insulin, FSH, LH, E2, total testosteron, homeostatic model assessment–insulin resistance (HOMA-IR), serum leptin and adiponectin levels were evaluated for all patients.


Of the 91 women with PCOS, 15 patients met the criteria for MetS. Body weight, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol, triglyceride, and VLDL concentrations were significantly higher and HDL was significantly lower in women with PCOS+MetS compared with those with PCOS only. However, the level of LDL, FSH, LH, E2 and total testesterone was not significantly different between these two groups. Women with PCOS+MetS had significantly higher levels of leptin and HOMA-IR, and significantly lower levels of adiponectin compared to the women with PCOS only. In the multiple logistic regression model, the association between HOMA-IR and leptin, and MetS remained statistically significant (p=0.001 and 0.018), while the association between adiponectin and MetS was no longer statistically significant.


Aside from the biochemical markers such as glucose, cholesterol and triglyceride, adipose tissue factors and insulin resistance are valuable parameters in the prediction of MetS in patients with PCOS.

Keywords: Metabolic syndrome, polycystic ovary syndrome, leptin, adiponectin, HOMA-IR